Ethereum, XRP, Solana Up Over 40% in 2 Weeks but 1 Altcoin Misses the Crypto Party
Bitcoin rally driven by spot demand and spreading to altcoins. Bitfinex sees $80,000 as key resistance. Nineteen altcoins gain over 12%.
Read original at benzingaMarkets · News reference
Gavin Newsom Fires Back as Trump Officials Halt More Than $1 Billion in Medicaid Payments to California, Minnesota Over Suspected Billing Scams: 'Being Targeted for Political Reasons...'
Trump admin pauses $1B in federal Medicaid payments to CA and MN, citing fraud. Gov. Newsom accuses of political targeting. CMS wants proof.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
No ticker was attached by the source feed.
- Source
- benzinga
- Observed
- Jul 22, 2026, 1:21 PM
- Checked
- Jul 22, 2026, 1:30 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Global Blood-Based Biomarkers Market to Witness Upsurge in Growth at a CAGR of ~9% by 2034 | DelveInsight
The global blood-based biomarkers market is projected to grow from USD 8.5 billion in 2025 to USD 18.5 billion by 2034, driven by increasing demand for non-invasive diagnostics, rising chronic disease prevalence, and advances in genomics and liquid biopsy technologies. North America leads with 44% market share, while Asia-Pacific shows fastest growth. Key players include Roche, Abbott, Siemens Healthineers, and Thermo Fisher Scientific.
Read original at globenewswire-incSoFi Technologies' SoFi Plus: Can Paid Membership Drive Growth?
SoFi Technologies relaunched its premium SoFi Plus membership in Q2 2026, reaching 206,000 paid subscribers with $24 million in annualized revenue. The subscription strategy is working, with 25% of subscribers adding additional products. Management aims for 1 million subscribers within a year, implying $120 million in annual revenue. Meanwhile, competitors Robinhood and Chime are expanding their financial services offerings.
Read original at zacks-investment-researchPRED sets sports trading fees below half the prediction market average
PRED, a peer-to-peer sports prediction exchange, has introduced trading fees averaging 1% for takers and 0% for makers, positioning itself as the lowest-cost option compared to competitors Kalshi (7%) and Polymarket (5%). The platform uses an identical fee calculation formula to competitors but with a lower coefficient of 2.5%, and has expanded football coverage to include La Liga, Champions League, Europa League, and MLS.
Read original at globenewswire-incLiquidia vs. Insmed: Which Pulmonary Stock Has Better Prospects Now?
Liquidia (LQDA) and Insmed (INSM) are compared as commercial-stage biopharmaceutical companies focused on pulmonary hypertension treatments. LQDA shows impressive commercial momentum with Yutrepia generating $170.4M in Q2 sales and achieving four consecutive profitable quarters, but faces heavy reliance on a single product. INSM offers a more diversified portfolio with Brinsupri's strong launch ($1.25-$1.40B 2026 guidance) and established Arikayce revenue, plus a broader pipeline. While LQDA has outperformed INSM significantly this year (106.9% vs -28.5%), analysts recommend INSM as the more compelling long-term choice due to its diversified revenue base and sustainable growth story.
Read original at zacks-investment-researchCBRS vs. AMD: Which Stock Leads the AI Infrastructure Boom?
Cerebras Systems and Advanced Micro Devices are both benefiting from AI infrastructure growth. While AMD offers greater scale, profitability and diversification with Data Center revenues more than doubling, Cerebras appears to have an edge with faster growth expectations, $25.4B in remaining performance obligations, and strong partnerships with OpenAI and AWS. Cerebras expects core revenues to more than triple in 2027, though it remains unprofitable with customer concentration risks.
Read original at zacks-investment-research